A new study reveals that combining natural antimicrobial peptides can significantly slow the development of antimicrobial resistance in bacteria. The research shows that using two peptides together prevents harmful bacteria from mutating as quickly, offering a promising alternative to traditional antibiotics. These findings could lead to safer, more sustainable disease control in livestock and agricultural settings.

Would you trade the ability to climb a flight of stairs for the assurance that your country is protecting democratic freedoms? A new study asked Americans to weigh surprising tradeoffs—health versus dignity, income versus rights, convenience versus environmental quality. The answers revealed consistent patterns in how people value very different aspects of life, offering a practical way to compare “apples and oranges” in policy decisions. The approach could help governments, hospitals, and other institutions design choices that reflect real human priorities.

A surprising new drug combo—including a compound found in chocolate—has outperformed Tamiflu in fighting the flu, according to a study published in PNAS. The mix of Theobromine and Arainosine proved far more effective against a range of flu strains, including drug-resistant versions of bird and swine flu. By targeting a key viral weakness, this breakthrough could lead to stronger, longer-lasting treatments—not just for the flu, but potentially for other viruses as well.

Researchers have discovered a way to make the immune system’s T cells significantly more effective at fighting cancer. By blocking a protein called Ant2, they were able to reprogram how these cells consume and generate energy—essentially rewiring their internal power supply. This shift makes T cells more active, resilient, and better at attacking tumors. The findings open the door to new treatments that could strengthen the body’s own immune response, offering a smarter, more targeted approach to cancer therapy.

The Hebrew University of Jerusalem is proud to announce a new international agreement with the Faculty of Dentistry at the Graduate School of Medical and Dental Sciences, Institute of Science, Tokyo. This agreement marks the beginning of a collaborative partnership focused on research, and the mutual exchange of students and academic staff.

The Tokyo institute is globally recognized for excellence. Its Faculty of Dentistry holds an impressive 4th place in QS 2025 Subject Rankings!

Open to researchers in water technology – no application deadline

The Young Scientists Exchange Program (YSEP) supports early-career researchers from Israel and Germany in gaining international experience and building academic collaborations in water technology. The program is part of the German-Israeli cooperation in this field, funded by the Israeli Ministry of Innovation, Science and Technology and the German Federal Ministry of Education and Research (BMBF).

Who Can Apply

Airovation Technologies was awarded the prestigious 2025 Asper Prize for “The Hebrew University Rising Startup”. The prize, part of a competition launched by ASPER-HUJI Innovate, the university’s Center for Innovation and Entrepreneurship in collaboration with the Asper Foundation, drew entries from more than fifty startups. Airovation Technologies secured the top spot after presenting to an international panel of judges.

Why do so many people relapse after quitting cocaine? A new study from The Hebrew University reveals that a specific “anti-reward” brain circuit becomes hyperactive during withdrawal—driving discomfort and pushing users back toward the drug. Surprisingly, this circuit may also serve as a built-in protective mechanism, offering new hope for addiction treatment.

In a major stride toward tackling aggressive breast cancer, researchers from The Hebrew University of Jerusalem have developed druglike molecules that degrade a previously “undruggable” cancer-driving protein. The target, HuR—an RNA-binding protein known for stabilizing oncogenic messages—has long eluded traditional therapies. Now, using next-generation strategies involving molecular glues and PROTACs, researchers have uncovered a promising route to disarm HuR and suppress tumor growth from the inside out.

A new study has uncovered how stress experienced by mothers during pregnancy leaves a molecular imprint on their babies—starting before birth. The research shows that prenatal stress alters the expression of tiny RNA molecules in newborn blood, particularly in female children, and affects key enzymes in the brain's stress-regulation system. These changes may help explain why some children are more vulnerable to developmental or psychiatric challenges. The study opens new possibilities for early diagnosis and interventions targeting stress-related health risks.

A promising new discovery from the Hebrew University of Jerusalem reveals that cross-linked hyaluronic acid (XHA) significantly enhances the retention and concentration of topical antibiotics in the tear film of dogs. Compared to traditional formulations using polyvinyl alcohol (PVA), the XHA-based eyedrops maintained higher drug levels for longer durations. This innovation not only suggests improved treatment outcomes for veterinary patients – it also carries meaningful implications for human medicine.